Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Novartis AG Common Stock
(NY:
NVS
)
131.26
-0.65 (-0.49%)
Official Closing Price
Updated: 4:10 PM EST, Nov 14, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,822,790
Open
132.46
Bid (Size)
128.42 (200)
Ask (Size)
134.00 (100)
Prev. Close
131.91
Today's Range
130.30 - 132.76
52wk Range
96.06 - 134.00
Shares Outstanding
N/A
Dividend Yield
3.04%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
AI Revolutionizes Drug Shelf-Life: Optimized Stability Models Promise Safer, More Effective Medicines
Today 14:21 EST
The pharmaceutical industry is on the cusp of a profound transformation, driven by the integration of data science and Artificial Intelligence (AI) into drug formulation stability models. This...
Via
TokenRing AI
Topics
Artificial Intelligence
Economy
Product Recall
Biopharma Boom: M&A Frenzy, AI Revolution, and GLP-1 Gold Rush Drive Robust Growth in 2025
Today 13:36 EST
The pharmaceutical and biotechnology sectors are experiencing a period of significant dynamism and robust growth as of November 2025, fueled by a confluence of scientific advancements, a resurgence in...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Intellectual Property
Performance
YTD
+35.1%
+35.1%
1 Month
+0.8%
+0.8%
3 Month
+7.5%
+7.5%
6 Month
+21.0%
+21.0%
1 Year
+26.4%
+26.4%
More News
Read More
Novartis Opens New Manufacturing Facility In California In Bid To Increase US Presence
↗
November 10, 2025
Via
Stocktwits
BIOCHINA2026 – Fusion Forward: Uniting the Global Biopharma Community in Suzhou
Today 11:00 EST
Via
Get News
AI Revolutionizes Cardiovascular Clinical Trials: A Leap Towards Cheaper, Faster Drug Development
November 13, 2025
Via
TokenRing AI
Topics
Artificial Intelligence
Novartis' Investigational Medicine Shows Potent Activity Against Drug-Resistant Malaria Strains
↗
November 13, 2025
Via
Benzinga
Eledon Pharmaceuticals Stock Plunges Following $50 Million Public Offering
November 12, 2025
Via
MarketMinute
Topics
Initial Public Offering
Intellectual Property
Regulatory Compliance
AI’s Next Frontier: Key Stocks to Watch Amidst Market Shifts and Technological Leaps
November 10, 2025
Via
TokenRing AI
Topics
Artificial Intelligence
AI Achieves Atomic Precision in Antibody Design: A New Era for Drug Discovery Dawns
November 05, 2025
Via
TokenRing AI
Topics
Artificial Intelligence
Intellectual Property
Celcuity Eyeing Cancer Treatment Riddle. Stock Flys 534% This Year.
↗
November 05, 2025
Via
Investor's Business Daily
AI Unleashes a New Era in Cell and Gene Therapy: A Quarter Century Update Reveals Transformative Potential
November 04, 2025
Via
TokenRing AI
Topics
Artificial Intelligence
Terns Pharmaceuticals' Leukemia Drug Seen As Potential Disruptor In CML Treatment Landscape, Analyst Upgrades
↗
November 03, 2025
Via
Benzinga
iShares Core MSCI EAFE ETF (IEFA) Focuses on Developed Markets While Vanguard FTSE All-World ex-US ETF (VEU) Looks Globally
↗
November 03, 2025
Via
The Motley Fool
Topics
ETFs
Trump Offers Help To 'Dilbert' Creator's Cancer Fight
↗
November 03, 2025
Via
Benzinga
Topics
Government
The Vanguard FTSE Developed Markets ETF (VEA) Offers Broader Diversification Than the SPDR Portfolio Developed World ex-US ETF (SPDW)
↗
November 02, 2025
Via
The Motley Fool
Topics
ETFs
Vanguard VEA ETF Boasts Broader Portfolio Than State Street's SPDR SPDW
↗
November 02, 2025
Via
The Motley Fool
Topics
ETFs
AI Unleashes a New Era: Biopharma’s Accelerated Revolution and the Rise of TechBio
November 01, 2025
Via
TokenRing AI
Topics
Animal Testing
Artificial Intelligence
Economy
The AI Imperative: Why Rapid Upskilling is Non-Negotiable for Pharma’s Future
October 31, 2025
Via
TokenRing AI
Topics
Artificial Intelligence
Economy
AI Revolutionizes Pharma: Smarter Excipients for Safer, More Potent Drugs
October 31, 2025
Via
TokenRing AI
Topics
Artificial Intelligence
Supply Chain
AI Revolutionizes Pharma R&D: A New Era of Accelerated Drug Discovery and Personalized Medicine
October 31, 2025
Via
TokenRing AI
Topics
Artificial Intelligence
Intellectual Property
AI: The Pharmaceutical Sector’s New Catalyst for a Healthier Future
October 31, 2025
Via
TokenRing AI
Topics
Animal Testing
Artificial Intelligence
Economy
Here's Why Avidity Biosciences Stock Soared This Week (There's More to the Deal Than You Might Think)
↗
October 31, 2025
Via
The Motley Fool
Here's My Favorite Passive Income Investment
↗
October 31, 2025
Via
The Motley Fool
Topics
ETFs
Is the Market Bullish or Bearish on Novartis AG?
↗
October 29, 2025
Via
Benzinga
United Therapeutics Dips As Bread-And-Butter Drug Comes Up Short
↗
October 29, 2025
Via
Investor's Business Daily
Frequently Asked Questions
Is Novartis AG Common Stock publicly traded?
Yes, Novartis AG Common Stock is publicly traded.
What exchange does Novartis AG Common Stock trade on?
Novartis AG Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novartis AG Common Stock?
The ticker symbol for Novartis AG Common Stock is NVS on the New York Stock Exchange
What is the current price of Novartis AG Common Stock?
The current price of Novartis AG Common Stock is 131.26
When was Novartis AG Common Stock last traded?
The last trade of Novartis AG Common Stock was at 11/14/25 04:10 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today